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Abstract
Background: On the basis of earlier experiences in Germany and England, we developed an intensive multimodal group
programme (FACT Plus) for psychotic-spectrum patients. By combining it with regular Flexible Assertive Community
Treatment (FACT) (care as usual), we intended to reduce psychiatric rehospitalizations and mental healthcare costs.
Methods:We included adult patients (>18 years) with a psychotic spectrum disorder who had had at least one psychiatric
admission in the 2 years before inclusion. FACT Plus was delivered weekly for 9 months. The intervention group was
recruited in northern Rotterdam (the Netherlands), and the control group was recruited in southern Rotterdam. The primary
outcome measure was length of stay (LOS) and the secondary outcome measures were mental healthcare costs and
compulsory admissions.
Results:We included 52 patients in the intervention group and 61 patients in the control group. During the 12-month
observation period, the mean LOS per patient was 15.2 (intervention group) and 34.6 (control group). This represents a
difference of 19.4 days (56.1%). This result was statistically significant (B = −.859, SE = .497, p = .042) in a regression
model correcting for baseline differences between the groups. Mean total mental healthcare costs per patient were
€21,098 in the intervention group) versus €25,054 in the control group, a difference of about €4000 per patient (16%).
In addition, there were zero compulsory admissions in the intervention group and nine in the control group.
Conclusions: After the addition of FACT Plus to regular FACT, psychiatric LOS was substantially lower in the intervention
group than in the control group. This result was accompanied by a limited reduction in mental healthcare costs.
Keywords: Community mental healthcare, Severe mental illness, Group therapy, Psychotic disorder, Psychiatric admission,
Mental healthcare costs
Background
The success of community-based treatment as a means
of preventing the admission of patients with severe men-
tal illness [1, 2] remains disappointing. The shortcomings
of this approach are demonstrated by the number of pa-
tients with a history of frequent voluntary or involuntary
psychiatric hospitalization [3–5]. Although assertive com-
munity treatment (ACT) [6] has been found to have some
positive effect for patients with severe mental illness with
regard to hospitalization, social outcome, and retention in
care, these effects are slight and the quality of evidence is
moderate at best [7].
Early this century, a variant of ACT called Flexible As-
sertive Community Treatment (FACT) was developed in
the Netherlands. While FACT provides routine commu-
nity mental health services when possible, it offers inten-
sive ACT when necessary [8, 9]. But whatever the exact
treatment programme, a group of patients with severe
mental illness remains, many of whom are frequently ad-
mitted to psychiatric hospital [3, 5]. To reduce readmis-
sions in this subgroup of severe mental illness patients,
we therefore sought an intervention that could be imple-
mented in addition to FACT.
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In Germany, positive results were shown by an interven-
tion known as the Munich Psychosis Information Project
[10], which used an intensive multimodal group programme.
Its interventions included psycho-education focussing on the
importance of antipsychotic drug adherence and family treat-
ment. Rehospitalizations during 12-month follow-up were
approximately 50% lower in the intervention group than in
the control group. Completer analysis showed this result to
be significant, whereas the result of intention-to-treat-ana-
lysis did not reach significance. This important difference be-
tween completer analysis and intention-to-treat-analysis may
be due to biases, e.g. selective drop out, so this result should
be interpreted with caution. A post hoc study with a seven-
year follow-up found that, overall, hospitalization rates, ad-
herence, and course of illness were still better in the inter-
vention group than in the control group [11].
This German programme was also adopted and
implemented in England as the Maintaining Adher-
ence Programme, where, in a pre-post design, it
significantly reduced in-patient bed days by 42% in
the intention-to-treat analysis and by 51% reduction
in the completer analysis [12]. The same study also
showed a significant cost reduction and very high
patient and staff satisfaction.




Unaware of any other group-format interventions associated
with reduced admissions in patients with severe mental illness
at risk of rehospitalization, we aimed to replicate the German
and English findings and decided to develop a Dutch adapta-
tion of these programmes, which we implemented in Dutch
FACT teams. We hypothesized that combining this intensive
multimodal group programme with regular FACT in a group
of patients at risk of rehospitalization would reduce voluntary
and involuntary hospitalizations, and also overall mental
healthcare costs, more than FACTas usual.
Intervention
Our intensive multimodal group programme, which we called
FACT Plus, added several interventions and activities to
FACT. It consisted of weekly 90-min group sessions for as
much as 9 months, plus two-weekly follow-up sessions for the
next 3 months. The programme involved psychoeducation, re-
covery planning, shared decision making, composing a crisis
plan, drug-therapy adherence monitoring, resocialization ac-
tivities, family interventions, and sport and lifestyle interven-
tions. To monitor the status and to promote the progress of
the programme, we used a digital support platform that sent
automatic text messages to remind participants of the sessions
and also supported the process for the participants, their fam-
ily members, and the professionals.
FACT Plus was carried out in a friendly living-room like
atmosphere that was designed to denote accessibility and
hospitality. Importantly, a free lunch was offered after every
morning session and before every afternoon session. Partici-
pants and professionals did the shopping for lunch together,
and also prepared the food. In this way, lunch was itself an
intervention, as it was intended to support resocialisation
and to educate the participants about healthy food and cost-
conscious shopping. Along with the programme, regular
FACTcare as usual was continued (see also Fig. 1).
Care as usual
Care as usual consisted of FACT teams providing assertive
community treatment for unstable and care-avoiding pa-
tients, and coordinated, multidisciplinary treatment and re-
covery-oriented care for stable long-term patients [8, 9]. Per
team, the mean number of patients is 200, all of whom are
treated for severe mental illness, mainly schizophrenia and
other psychotic disorders. To promote comparable quality of
care in all FACT teams, teams are regularly audited on the
basis of well-described standards and criteria.
Design
This pilot study had a quasi-experimental controlled study de-
sign. Participants received the FACT Plus programme in com-
bination with FACT. The control patients received regular
FACT only (i.e. care as usual). On the basis of the intention-
to-treat principle, all patients who entered the study were in-
cluded in the outcome analyses, including those who dropped
out of the intervention early. According to this design, we
conducted a prospective intervention study with an interven-
tion group and a control group. The observation period for
both groups was 12months. While the observation period for
the participants started at inclusion, a fixed observation period
was chosen for the controls after all eligible patients had been
identified (1 April 2016–31 March 2017).
Outcome measures
The primary outcome measure was psychiatric hospitalization,
which was expressed as the length of stay (LOS) in days. Sec-
ondary outcome measures were the number of hospitaliza-
tions, the mental healthcare costs, and the number of
compulsory admissions. Mental healthcare costs consisted of
actual costs for outpatient care, including the expended staff
time for the group sessions in the intervention group, in-
patient care, and additional costs for the programme, such as
lunches and materials in the intervention group. Basic demo-
graphic, clinical and outcome data was collected for both
groups.
Setting
Participants and controls were recruited from the FACT
teams at the Parnassia Psychiatric Institute, a mental
health organization in the Netherlands’ greater Rotterdam
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area. FACT Plus was delivered to patients living in north-
ern Rotterdam, whereas patients in the control group were
selected in southern Rotterdam. While the organization,
procedures, staff, and patients of the FACT teams in both
parts of the city were very comparable, they were clearly
separated geographically by the river Maas. Professionals
involved in the intervention programme did not work in
the control-group teams and vice versa.
One psychiatric hospital on either side of the river
Maas was available for all patients included in the study.
While patients in the intervention group were admitted
to the hospital in northern Rotterdam, some patients in
the control group were allocated to the northern hos-
pital and some to the southern hospital. The two hospi-
tals used identical admission and discharge criteria,
which were documented in a service-delivery agreement
covering all psychiatric hospitals within the region. The
annual mean length of stay in the research period was
comparable between the two hospitals.
Participants
Adult patients (> 18 years) in the regular treatment of a
FACT team were eligible for the study if they had been
admitted to a psychiatric hospital at least once in the 2
years before inclusion. This admission criterion was applied
in order to select patients at the highest risk of rehospitaliza-
tion and those who accounted for the highest mental health-
care costs. We included only patients with a diagnosis,
according to the DSM-IV, [13] in the psychotic spectrum
(schizophrenia, schizoaffective disorder, psychotic disorder
not otherwise specified (NOS), and delusional disorder). Pa-
tients with severe learning disabilities, severe conduct disor-
ders, and severe language barriers were excluded. We
included 52 patients in the intervention group and 61 pa-
tients in the control group.
Table 1 summarizes the baseline characteristics of the
two groups. While, overall, participants and controls had
identical characteristics, more participants in the intervention
group had schizophrenia (71.2% versus 50.8%, respectively),
Fig. 1 Core points of FACT Plus and FACT
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whereas more participants in the control group had psychotic
disorder NOS (34.4% versus 17.3%). And while more patients
in the intervention group used depot medication, a slightly
higher number of patients in the control group used no anti-
psychotic medication.
Ethical issues and data processing
Our study was approved by the Medical Ethics Committee
at Leiden University Medical Centre. All participants in the
intervention group signed the informed consent form prior
to inclusion. However, as the control patients were not sub-
jected to any assessment or study intervention, the medical
ethics committee waived their obligation of informed con-
sent. All patient-related data concerning participants and
control group were also carefully anonymized, each patient’s
data coded with a research number. The hospitalization data
and mental healthcare costs of each group were collected
from the electronic patient registration system of the Parnas-
sia Psychiatric Institute. Information on whether participants
or controls had been hospitalized in other mental health in-
patient care facilities was gathered by the first author (MJ),
who scrutinized all patient files.
Statistical analysis
Descriptive statistics were used to explore the demographic
and clinical differences between the intervention and control
groups. In view of the hypothesis that the intervention would
lead to reduced LOS, statistical tests were one-sided, with
the statistical significance level set at 5%. Due to the small
sample size, correction for multiple testing was waived. To
evaluate the treatment effect, generalized linear models were
constructed in which we corrected for possible baseline dif-
ferences between the groups. To investigate the difference in
LOS, we used the negative binomial distribution with loglink,
which concerns count data with a high number of zeroes.
The gamma distribution was then applied to evaluate differ-
ences in right-skewed, positive and continuous data on men-
tal healthcare costs. All statistical analyses were conducted
using SPSS software (IBM SPSS version 24.0).
Results
Primary outcome
During the 12-month observation period in the interven-
tion group, the mean LOS was 15.2 days per patient versus
34.6 days in the control group – a difference of 19.4 days
(56.1%) in LOS between the two groups. After correction
for potential differences between the groups in terms of
age, gender, diagnosis, antipsychotics and drug abuse, the
final model showed a statistically significant difference in
LOS (B = -.859, SE = .497, p = .042). Table 2 summarizes the
outcomes and sensitivity analyses.
Secondary outcomes
The number of hospitalizations did not differ between the
two groups (39 in the intervention group versus 38 in the
control group). During 12-month follow-up, the mean total
mental healthcare costs per patient were €21,098 in the
intervention group (including the costs of FACT Plus) versus
€25,054 in the control group, a difference of about €4000 per
patient (16%). In a regression analysis this difference in costs
was not statistically significant (B = -.196, SE = .207, p= .172).
In the model we used identical corrections for potential dif-
ferences between the intervention and control groups, as we
did for the primary outcome. The additional costs for the
FACT Plus program for lunches and materials added €135
on average to the total per patient, which is a very small pro-
portion of the mean total costs of €21,098 per patient in the
intervention group.
During follow-up, there were no compulsory admis-
sions in the intervention group versus nine in the con-
trol group. These numbers were too small for further
statistical analysis.
Sensitivity analyses
Despite fulfilling all the inclusion criteria, five patients
in the control group turned out on the first day of
the chosen observation to have been hospitalized.
During the follow-up period, another patient in the
control group was hospitalized for more than 300 days
(outlier). After exclusion of the patients who were in
hospital at the start of the observation period, sensi-
tivity analyses regarding the number of hospitalization
days showed that the difference in LOS between the
two groups was somewhat smaller (B = −.554, SE =
.492, p = .13). Otherwise, when we excluded the out-
lier, again the difference in LOS (B = −.614, SE = .489,
p = .10) changed only slightly.
Table 1 Demographic and clinical characteristics of participants
and controls
Variable Participants N (%) Controls N (%)
N 52 61
Age (mean, yrs) 37.5 42.7
Male gender 33 (63.5) 40 (65.6)
Classification (DSM-IV)
Schizophrenia 37 (71.2) 31 (50.8)
Schizoaffective disorder 6 (11.5) 8 (13.1)
Psychotic disorder NOS 9 (17.3) 21 (34.4)
Delusional disorder 0 (0.0) 1 (1.6)
Antipsychotics
No 1 (1.9) 8 (13.1)
Oral 30 (57.7) 34 (55.7)
Clozapine 7 (13.5) 11 (18.0)
Depot 21 (40.4) 19 (31.1)
Dx of addiction (except nicotine) 30 (57.7) 30 (49.2)
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With regard to costs, the exclusion of the patients hos-
pitalized at baseline, the model showed a difference in
costs in favour of the control group (B = .237, SE = .206,
p = .125). Otherwise, when we excluded the outlier, there
was a small difference in costs in favour of the interven-
tion group (B = -.026, SE = .197, p = .448).
Discussion
Main results
Our results showed that mean length of stay (LOS) 56.1%
lower for patients who had participated in the FACT Plus
intensive multimodal group programme than it was for
patients in the control group. After the 12-month obser-
vation period, we observed a limited saving of about
€4000 per patient with regard to the total mental health-
care costs in the intervention group compared to the con-
trol group. The outcomes may be the product of various
factors within an assertive and integrated approach, espe-
cially a welcoming environment, psychoeducation, the
promotion of adherence, the involvement of families, and
the strong fellow-feeling between the patients themselves.
As the number of admissions did not differ signifi-
cantly between the two groups, we might state that while
similar numbers of patients from the two groups were
hospitalized during the observation period, the LOS in
the intervention group was considerably shorter. A pos-
sible explanation is that patients in the intervention
group were in more frequent touch with their healthcare
workers and could more quickly be discharged back to
the FACT Plus programme. Once back in FACT Plus,
they could then be monitored more closely. It is also
possible that this closer contact resulted in fewer – zero
versus nine – compulsory admissions, a subcategory of
admissions which indicates high illness severity and low
treatment adherence [14, 15].
Comparison of our study with the studies in Germany and
England [10, 12] reveals similarities and differences regarding
the programmes themselves and their study designs. First,
the content of each programme was very similar, focusing on
psychoeducation on the psychiatric condition, and also on
adherence and preventing rehospitalization. Second, while
the English programme was provided to individual patients,
our programme and the German programme were provided
in groups. Third, while the German programme lasted for 4
to 5 months, the English one was extended to 18months,
and ours lasted for between nine and 12months. The study
designs also differed: while we chose a quasi-experimental
non-randomized controlled study, the German study used
block randomization to allocate patients to the intervention
group or control group, and the English study used a pre-
post design. Despite these differences, however, the three
studies had comparable results.
Strengths and limitations
This study included patients who were difficult to en-
gage in treatment and care, and who would probably
have been even more difficult to include in research
studies. It was designed with a minimum of exclusion
criteria, and was carried out in the context of routine
daily FACT. At the design stage we considered the ad-
vantages and disadvantages of randomization, and par-
ticularly wished to avoid selection bias, which would
have arisen if any of the most seriously ill patients had
not been included because they refused to sign the in-
formed consent form. For this reason we accepted the
disadvantage of non-randomized allocation to the inter-
vention group and control group. Despite this, the num-
ber of patients enrolled in this pilot study remained
rather small and a larger sample size would be required
for more definitive answers.
In the sensitivity analyses – which left out 1.) control pa-
tients who had were already been admitted at the start of
the observation period and 2.) the control group patient
had been in hospital for more than 300 days during the
observation period – the outcomes with regard to LOS
were only moderately attenuated, but did not change es-
sentially. However, the outcomes with regard to costs were
considerably attenuated in the sensitivity analyses.
The intervention consisted of a nine-month multimodal
group programme with one weekly session. However, as
with the preceding German and English studies, its design
Table 2 Hospitalization days and total mental healthcare costs (summary of outcomes and sensitivity analyses)
Outcome Intervention group Control group Group parameter
Hospitalization days (Mean and SD) 15.2 (32.2) 34.6 (76.4)
- Adjusted (estimated mean and SE)a 14.7 (5.4) 34.6 (11.7) -.859 (p = .042)
- Excluding baseline hospitalized patients 14.7 (5.4) 25.5 (8.5) -.554 (p = .13)
- Excluding outlier 13.6 (4.8) 25.1 (8.7) -.614 (p = .10)
Total mental healthcare costs € (Mean and SD) 21,098 (18,659) 25,054 (39,196)
- Adjusted (estimated mean and SE)a 21,501 (3262) 26,152 (3820) −.196 (p = .172)
- Excluding baseline hospitalized patients 22,895 (3317) 18,070 (2675) .237 (p = .125)
- Excluding outlier 20,249 (2890) 20,778 (2989) −.026 (p = .448)
aModel includes casemix factors (medication formulation, psychosis, drug abuse, gender and age grand mean centered); Wald-test, one-sided P-values
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did not allow us to establish which elements of the inter-
vention were responsible for the effects we observed.
Overall, ours is the third study after its German and
English forerunners to test this intensive multimodal
group programme. With regard to the reduction in LOS –
roughly 50% in all three studies – and in mental health-
care costs, its results are strikingly similar.
Conclusions
After this intensive multimodal group programme (FACT
Plus), patients with psychotic disorders who risked rehospi-
talization spent 19.4 fewer days (56.1%) in psychiatric
hospitalization than patients in care as usual (FACT). This
promising result was accompanied by a limited reduction in
mental healthcare costs. These findings indicate that FACT
Plus, a Dutch adaptation of comparable programmes in
Germany and England, may make meaningful improvements
to FACT – and possibly to other community mental health
teams – for patients with a psychotic disorder who risk re-
hospitalization. More generally, these findings also indicate
that combining an intensified treatment programme with
regular mental healthcare in the community may be a valu-
able add-on for the most vulnerable psychiatric patients risk-
ing rehospitalization.
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